World's Best Scientists 2026 revealed!
Philippe Ruszniewski

Philippe Ruszniewski

D-Index & Metrics

Medicine

D-Index
120
Citations
51326
World Ranking
3765
National Ranking
109

Overview

Philippe Ruszniewski is affiliated with Université Paris Cité in France and has contributed extensively to medical research, particularly in the field of neuroendocrine tumors and oncology. Their scholarly work includes numerous publications primarily centered on neuroendocrine tumor research, lung cancer, neuroblastoma, and pancreatic and hepatic oncology.

The main field of study for Ruszniewski is Medicine, with a focus on Oncology, Epidemiology, and Neurology, reflecting a broad engagement across various interconnected medical sciences. Specific subfields include:

  • Oncology
  • Epidemiology
  • Neurology
  • Public Health, Environmental and Occupational Health
  • Surgery

The primary topics of research encompass:

  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Neuroblastoma Research and Treatments
  • Pancreatic and Hepatic Oncology Research
  • Pancreatitis Pathology and Treatment
  • Innovations in Medical Education
  • Clinical Reasoning and Diagnostic Skills

Ruszniewski has collaborated frequently with other researchers in the field. Notable co-authors include Louis de Mestier, Olivia Hentic, Jérôme Cros, Anne Couvelard, and Alain Sauvanet, with collaboration counts ranging from 13 to 41 joint publications.

Prominent venues where their research has been published include:

  • Pancreatology
  • Endocrine Related Cancer
  • Annals of Oncology
  • Journal of Neuroendocrinology
  • Neuroendocrinology

Selected recent publications by Ruszniewski include:

  • European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes, 2023, Journal of Neuroendocrinology
  • Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR), 2020, Digestive and Liver Disease
  • Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study, 2020, European Journal of Nuclear Medicine and Molecular Imaging
  • Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms, 2021, Endocrine Related Cancer
  • Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results, 2021, European Journal of Cancer

Best Publications

  • Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

    Eric Raymond;Laetitia Dahan;Jean Luc Raoul;Yung Jue Bang

  • Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

    Jonathan Strosberg;G. El-Haddad;Edward Wolin;A. Hendifar

  • Gastroenteropancreatic neuroendocrine tumours.

    Irvin M Modlin;Kjell Oberg;Daniel C Chung;Robert T Jensen

  • Lanreotide in metastatic enteropancreatic neuroendocrine tumors.

    Martyn E. Caplin;Marianne Pavel;Jarosław B. Ćwikła;Alexandria T. Phan

  • Daily Oral Everolimus Activity in Patients with Metastatic Pancreatic Neuroendocrine Tumors after Failure of Cytotoxic Chemotherapy: A Phase II Trial

    James C. Yao;Catherine Lombard-Bohas;Eric Baudin;Larry K. Kvols

  • Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

    Kjell Öberg;L. Kvols;M. Caplin;G. Dell Fave

  • Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

    Martyn E. Caplin;E. Baudin;P. Ferolla;P. Filosso

  • Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

    U. Plöckinger;G. Rindi;R. Arnold;B. Eriksson

  • Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

    Florence Huguet;Thierry André;Pascal Hammel;Pascal Artru

  • Regression of Liver Fibrosis after Biliary Drainage in Patients with Chronic Pancreatitis and Stenosis of the Common Bile Duct

    Pascal Hammel;Anne Couvelard;Dermot O'Toole;Anne Ratouis

  • Risk of pancreatic adenocarcinoma in chronic pancreatitis

    D Malka;P Hammel;F Maire;P Rufat

  • ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.

    G. Delle Fave;D. O'Toole;Anders Sundin;B. Taal

  • TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study

    Guido Rindi;M Falconi;C Klersy;L Albarello

  • Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct.

    B Terris;P Ponsot;F Paye;P Hammel

  • Pancreatic involvement in von Hippel–Lindau disease

    Pascal R. Hammel;Valerie Vilgrain;Benoit Terris;Alfred Penfornis

  • Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses

    M Voss;P Hammel;G Molas;L Palazzo

  • Risk factors for diabetes mellitus in chronic pancreatitis

    David Malka;Pascal Hammel;Alain Sauvanet;Pierre Rufat

  • Assessment of complications of EUS-guided fine-needle aspiration.

    Dermot O'Toole;Laurent Palazzo;Ramuntçho Arotçarena;Alain Dancour

  • Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy

    Sébastien Gaujoux;Alexandre Cortes;Anne Couvelard;Séverine Noullet

  • ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms

    Gianfranco Delle Fave;Dik J. Kwekkeboom;Erik Van Cutsem;Guido Rindi

Frequent Co-Authors

Pascal Hammel
Pascal Hammel University of Paris-Saclay
Anne Couvelard
Anne Couvelard Université Paris Cité
Alain Sauvanet
Alain Sauvanet Université Paris Cité
Jacques Belghiti
Jacques Belghiti Beaujon Hospital
Valérie Vilgrain
Valérie Vilgrain Université Paris Cité
Guido Rindi
Guido Rindi Catholic University of the Sacred Heart
Kjell Öberg
Kjell Öberg Uppsala University
Eric Raymond
Eric Raymond St. Joseph Hospital
Eric Baudin
Eric Baudin Institut Gustave Roussy

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in medicine or healthcare in the USA, several flexible and accredited online degree pathways can help you advance or diversify your qualifications. Online MHA programs are popular among professionals aiming for leadership or administrative roles in health systems. These programs offer the convenience of remote learning while maintaining the high standards required for healthcare management.

For nurses eager to upskill, rn to bsn programs without clinicals provide a streamlined path to a bachelor's degree, often allowing working RNs to advance without the additional time commitment of in-person clinical work. Similarly, nurses and advanced practitioners looking to earn their doctorate quickly may benefit from the shortest post master's dnp program options available entirely online.

For those concerned about research requirements, there are also dnp programs without dissertation, removing a major barrier and further easing the pathway to advanced practice or leadership. These options make it easier to find a degree program tailored to specific career goals in the healthcare field.

Best Scientists Citing Philippe Ruszniewski

Trending Scientists

Recently Published Articles